Advisory Alpha, LLC - SAREPTA THERAPEUTICS INC ownership

SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 375 filers reported holding SAREPTA THERAPEUTICS INC in Q1 2019. The put-call ratio across all filers is 0.75 and the average weighting 0.2%.

Quarter-by-quarter ownership
Advisory Alpha, LLC ownership history of SAREPTA THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$326,082
+5.9%
2,6900.0%0.02%
+6.2%
Q2 2023$308,059
-16.9%
2,6900.0%0.02%
-33.3%
Q1 2023$370,763
+6.4%
2,6900.0%0.02%
-4.0%
Q4 2022$348,570
+9.6%
2,690
-6.4%
0.02%
+4.2%
Q3 2022$318,000
+47.2%
2,8750.0%0.02%
+50.0%
Q2 2022$216,000
-4.0%
2,8750.0%0.02%
+6.7%
Q1 2022$225,000
-19.4%
2,875
-7.3%
0.02%
-6.2%
Q4 2021$279,000
-2.8%
3,1000.0%0.02%
-20.0%
Q3 2021$287,000
+13.4%
3,100
-4.6%
0.02%
-4.8%
Q2 2021$253,0000.0%3,250
-4.1%
0.02%
-16.0%
Q1 2021$253,000
-58.1%
3,390
-4.2%
0.02%
-79.7%
Q4 2020$604,000
+16.4%
3,540
-0.6%
0.12%
+10.8%
Q3 2020$519,000
-7.7%
3,5600.0%0.11%
-10.5%
Q2 2020$562,000
-99.9%
3,5600.0%0.12%
+7.8%
Q1 2020$410,504,000
-7.5%
3,5600.0%0.12%
+6.5%
Q4 2019$443,683,000
+54.3%
3,5600.0%0.11%
+27.1%
Q3 2019$287,577,000
+54057.6%
3,5600.0%0.08%
-52.0%
Q2 2019$531,000
-99.9%
3,5600.0%0.18%
+15.7%
Q1 2019$423,426,000
+93578.3%
3,5600.0%0.15%
-28.2%
Q4 2018$452,0003,5600.21%
Other shareholders
SAREPTA THERAPEUTICS INC shareholders Q1 2019
NameSharesValueWeighting ↓
Perceptive Advisors 2,878,979$69,182,0007.27%
Eventide Asset Management 259,100$6,226,0000.97%
GLADE BROOK CAPITAL PARTNERS LLC 251,000$6,032,0000.93%
IMS Capital Management 32,215$774,0000.91%
Perceptive Advisors 350,000$8,413,0000.88%
Benchmark Capital Advisors 34,900$839,0000.58%
BECK CAPITAL MANAGEMENT, LLC 24,744$636,0000.49%
SABBY MANAGEMENT, LLC 352,100$8,461,0000.47%
Hatteras Alternative Mutual Funds, LLC 39,404$947,0000.46%
Potomac Capital Management, Inc. 22,100$531,0000.45%
View complete list of SAREPTA THERAPEUTICS INC shareholders